The global Benign Prostatic Hyperplasia (BPH) treatment market is poised for significant expansion over the next decade. According to recent market analysis, the BPH treatment market was valued at USD 1.57 billion in 2023 and is projected to reach USD 3.38 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.92% during the forecast period from 2024 to 2032. Get Free Sample...